Skip to main content
logo
NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0610
-0.0040 (-6.15%)
Sep 18, 2026, 1:45 PM AEST

ASX:NSB Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
25232961126
Market Cap Growth
-53.84%-20.53%400.23%-49.60%-55.56%-46.27%
Enterprise Value
2117242816
Last Close Price
0.070.060.090.040.080.18

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
---17.84--
PS Ratio
62.9157.10-2.622.32-
PB Ratio
1.711.551.721.082.444.68
P/TBV Ratio
5.585.073.991.172.604.97
P/FCF Ratio
---136.31--
P/OCF Ratio
---130.72--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
51.6341.32-1.111.65-
EV/EBITDA Ratio
---9.93--
EV/EBIT Ratio
---15.76--
EV/FCF Ratio
---57.68--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.010.01----
Net Debt / Equity Ratio
-0.31-0.31-0.43-0.93-1.05-1.31
Net Debt / EBITDA Ratio
1.371.373.79-20.094.410.69
Net Debt / FCF Ratio
1.641.646.46-116.752.131.04
Asset Turnover
0.030.03-0.410.76-
Quick Ratio
14.1614.1649.3558.468.303.31
Current Ratio
14.2714.2749.5658.878.393.34
Return on Equity (ROE)
-29.68%-29.68%-16.65%6.46%-20.93%-103.71%
Return on Assets (ROA)
-18.30%-18.30%-11.21%1.81%-11.24%-58.19%
Return on Capital Employed (ROCE)
-31.70%-31.70%-11.90%2.90%-25.00%-190.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-18.53%-20.41%-6.38%5.61%-9.31%-40.41%
FCF Yield
-10.97%-12.08%-3.89%0.73%-20.08%-26.90%
Buyback Yield / Dilution
-129.96%-129.96%-1.49%-0.72%--